China

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
7.18 (5.85 - 8.69)	2015	Modelled	WHO
6.1 (5.50 - 6.90)	2016	Modelled	Razavi-Shearer et al, 2018
7.2 (6.70 - 7.70)	2006	Survey/reported	Liang et al, 2009
6.89 (5.84 - 7.95)	2017	Modelled	Wang et al, 2019
5.49 (5.47 - 5.50)	2013	Modelled	Schweitzer et al, 2015
9.75 (4.49 - 17.85)	1992	Survey/reported	Xia et al, 1996
7.83 (6.95 - 8.75)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
8.49 (7.55 - 9.44)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
8.61 (7.65 - 9.56)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
8.85 (7.89 - 9.78)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
9.06 (8.09 - 10)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
9.14 (8.19 - 10.07)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
9.27 (8.33 - 10.22)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
9.43 (8.50 - 10.38)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
9.57 (8.64 - 10.53)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
9.66 (8.74 - 10.63)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
9.78 (8.85 - 10.75)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
9.99 (9.04 - 10.98)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
10.25 (9.25 - 11.26)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
10.51 (9.45 - 11.54)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
10.73 (9.65 - 11.78)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
11 (9.87 - 12.11)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
11.41 (10.19 - 12.61)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
11.84 (10.56 - 13.12)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
12.2 (10.83 - 13.59)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
12.4 (10.98 - 13.81)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
12.46 (11.07 - 13.87)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
12.49 (11.16 - 13.87)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
12.5 (11.22 - 13.84)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
12.5 (11.26 - 13.78)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
12.51 (11.28 - 13.79)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
12.54 (11.32 - 13.79)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
12.58 (11.34 - 13.81)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
12.64 (11.37 - 13.89)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
12.7 (11.41 - 13.96)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
12.77 (11.46 - 14.06)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
8.38 (7.46 - 9.34)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.83 (0.56 - 1.18)	2015	Modelled	WHO
0.3 (0.20 - 0.50)	2014	Survey/reported	WHO WPRO, Woodring J et al, 2017
0.42 (0.34 - 0.51)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
0.55 (0.44 - 0.66)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
0.56 (0.45 - 0.68)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
0.57 (0.46 - 0.70)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
0.58 (0.47 - 0.70)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
0.6 (0.48 - 0.71)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
0.61 (0.49 - 0.73)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
0.63 (0.51 - 0.75)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
0.65 (0.53 - 0.77)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
0.67 (0.55 - 0.81)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
0.71 (0.58 - 0.85)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.94)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.09)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1.11 (0.90 - 1.32)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1.36 (1.11 - 1.61)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1.66 (1.35 - 1.97)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
2.8 (2.28 - 3.32)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
5.03 (4.08 - 5.99)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
7.56 (6.14 - 8.99)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
9.65 (7.83 - 11.50)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
10.61 (8.60 - 12.63)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
10.74 (8.76 - 12.71)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
10.81 (8.91 - 12.75)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
10.84 (8.99 - 12.73)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
10.85 (9.02 - 12.72)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
10.86 (9.02 - 12.72)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
10.87 (9.04 - 12.72)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
10.88 (9.06 - 12.73)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
10.88 (9.08 - 12.73)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
10.89 (9.08 - 12.72)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
10.89 (9.05 - 12.73)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
0.22 (0.18 - 0.28)	2020	Modelled	WHO

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
86,007,000 (77,170,000 - 97,466,000)	2016	Modelled	Razavi-Shearer et al, 2018
111,316,000 (98,865,200 - 124,425,000)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
114,175,000 (101,609,000 - 127,251,000)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
115,138,000 (102,614,000 - 128,219,000)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
116,185,000 (103,401,000 - 128,898,000)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
118,784,000 (105,917,000 - 130,941,000)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
120,924,000 (107,926,000 - 133,589,000)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
121,359,000 (108,767,000 - 133,777,000)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
122,495,000 (110,011,000 - 135,153,000)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
123,884,000 (111,640,000 - 136,310,000)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
125,104,000 (113,023,000 - 137,710,000)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
125,738,000 (113,563,000 - 138,613,000)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
126,712,000 (114,530,000 - 139,507,000)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
128,840,000 (116,344,000 - 141,765,000)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
131,542,000 (118,618,000 - 144,657,000)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
134,244,000 (120,839,000 - 147,671,000)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
136,396,000 (122,568,000 - 150,001,000)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
139,308,000 (124,884,000 - 153,387,000)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
143,813,000 (128,532,000 - 158,955,000)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
148,624,000 (132,243,000 - 164,986,000)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
152,453,000 (135,152,000 - 169,400,000)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
153,978,000 (136,352,000 - 171,581,000)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
153,592,000 (136,292,000 - 170,368,000)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
152,718,000 (136,429,000 - 169,066,000)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
151,556,000 (136,103,000 - 167,289,000)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
150,302,000 (135,212,000 - 165,725,000)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
149,139,000 (134,346,000 - 163,830,000)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
148,150,000 (133,461,000 - 162,617,000)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
147,272,000 (132,590,000 - 161,654,000)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
146,469,000 (131,666,000 - 160,887,000)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
145,702,000 (130,741,000 - 160,284,000)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
144,940,000 (129,917,000 - 159,800,000)	1990	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
11.4 (9.33 - 13.70)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
19.32 (16.41 - 22.86)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
19.88 (17.10 - 22.97)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
20.29 (17.58 - 23.36)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
20.7 (18.11 - 23.68)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
21.07 (18.63 - 23.74)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
21.33 (19.06 - 23.85)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
21.07 (19.01 - 23.34)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
21.27 (19.35 - 23.45)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
21.43 (19.43 - 23.81)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
20.8 (18.93 - 22.96)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
19.94 (18.03 - 22.14)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
16.15 (14.56 - 18.11)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
18.31 (16.37 - 20.34)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
14.36 (12.99 - 15.87)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
13.14 (11.85 - 14.61)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
12.17 (11.01 - 13.41)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
12.5 (11.33 - 13.90)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
11.97 (10.88 - 13.14)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
12.05 (10.91 - 13.26)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
11.69 (10.49 - 13.10)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
11.87 (10.74 - 13.13)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
11.37 (10.11 - 12.66)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
11.04 (9.90 - 12.41)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
10.81 (9.44 - 12.36)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
10.79 (9.43 - 12.31)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
10.86 (9.45 - 12.49)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
11.05 (9.35 - 12.77)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
11.19 (9.43 - 13.11)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
11.23 (9.35 - 13.35)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
11.4 (9.33 - 13.72)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
333,320	2016	Modelled	WHO
228,718 (194,194 - 270,608)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
238,246 (204,895 - 275,324)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
245,998 (213,110 - 283,272)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
253,744 (221,973 - 290,245)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
260,890 (230,718 - 294,008)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
270,305 (245,086 - 300,320)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
266,662 (238,286 - 298,078)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
270,514 (246,081 - 298,211)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
268,633 (244,493 - 296,526)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
270,075 (243,638 - 299,162)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
259,334 (234,528 - 287,887)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
239,642 (214,259 - 266,254)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
212,669 (191,633 - 238,414)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
174,747 (157,589 - 194,288)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
190,058 (171,905 - 210,087)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
163,252 (147,706 - 179,921)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
167,066 (151,330 - 185,654)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
161,384 (146,709 - 177,145)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
161,306 (146,022 - 178,400)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
163,065 (147,708 - 179,529)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
159,449 (143,176 - 178,761)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
155,723 (138,467 - 173,474)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
151,898 (136,231 - 170,715)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
149,420 (130,514 - 170,751)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
155,068 (131,188 - 179,180)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
149,695 (130,852 - 170,833)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
151,493 (131,791 - 174,152)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
157,841 (133,101 - 184,965)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
159,172 (132,512 - 189,118)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
162,085 (132,642 - 195,155)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
162,085 (132,642 - 195,155)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
183 (159 - 211)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
192 (171 - 218)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
201 (181 - 222)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
210 (192 - 232)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
221 (202 - 239)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
234 (216 - 251)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
229 (211 - 249)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
237 (219 - 255)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
237 (219 - 254)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
231 (214 - 249)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
215 (197 - 232)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
190 (172 - 207)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
157 (144 - 169)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
129 (120 - 140)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
109 (101 - 118)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
101 (94 - 110)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
101 (94 - 109)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
101 (94 - 108)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
102 (95 - 109)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
100 (92 - 109)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
96 (88 - 104)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
97 (90 - 106)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
96 (89 - 105)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
99 (92 - 109)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
103 (95 - 112)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
109 (99 - 119)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
107 (97 - 117)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
110 (99 - 121)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
110 (98 - 122)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
110 (97 - 123)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
62 (58 - 67)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Coverage of HepB birth dose

Newborns

Download

Value (%)	Year	Type	Source
96	2019	Survey/reported	WHO/UNICEF
96	2018	Survey/reported	WHO/UNICEF
96	2017	Survey/reported	WHO/UNICEF
96	2016	Survey/reported	WHO/UNICEF
96	2015	Survey/reported	WHO/UNICEF
94	2014	Survey/reported	WHO/UNICEF
99	2013	Survey/reported	WHO/UNICEF
96	2012	Survey/reported	WHO/UNICEF
95	2011	Survey/reported	WHO/UNICEF
92	2010	Survey/reported	WHO/UNICEF
93	2009	Survey/reported	WHO/UNICEF
91	2008	Survey/reported	WHO/UNICEF
86	2007	Survey/reported	WHO/UNICEF
88	2006	Survey/reported	WHO/UNICEF
86	2005	Survey/reported	WHO/UNICEF
76	2004	Survey/reported	WHO/UNICEF
95	2020	Survey/reported	WHO/UNICEF
95	2021	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
99	2019	Survey/reported	WHO/UNICEF
99	2020	Survey/reported	WHO/UNICEF
99	2021	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
4 (3 - 6)	2015	Survey/reported	National Health and Family Planning Commission of the People's Republic of China, 2015.

Technical notes

HBV National Action Plan

HBV elimination goal

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

2002

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Most (61-100%)

Source: WHO

% of substance use disorder facilities offering hepatitis treatment

Many (31-60%)

Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
0.7 (0.50 - 0.80)	2015	Modelled	Blach et al, 2017
0.8 (0.20 - 1.20)	2014	Survey/reported	Gower et al, 2014
1.4 (1.12 - 1.75)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
1.39 (1.11 - 1.72)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
1.34 (1.07 - 1.67)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
1.08 (0.86 - 1.34)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
0.84 (0.67 - 1.03)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
0.84 (0.67 - 1.04)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
0.85 (0.68 - 1.05)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
0.87 (0.69 - 1.07)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.09)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.10)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.09)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
0.87 (0.69 - 1.07)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
0.85 (0.68 - 1.05)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
0.84 (0.66 - 1.04)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
0.83 (0.66 - 1.03)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
0.85 (0.67 - 1.05)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
0.89 (0.70 - 1.10)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
0.94 (0.74 - 1.17)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1.01 (0.79 - 1.26)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1.08 (0.85 - 1.34)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1.17 (0.93 - 1.45)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
1.31 (1.05 - 1.61)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
1.46 (1.17 - 1.79)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
1.61 (1.30 - 1.95)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
1.73 (1.40 - 2.09)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
1.84 (1.49 - 2.23)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
1.94 (1.57 - 2.37)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
2.05 (1.65 - 2.51)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
2.15 (1.72 - 2.64)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
2.24 (1.79 - 2.77)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
1.34 (1.06 - 1.67)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
0.67 (0.45 - 0.74)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
1.21	2019	Modelled	Jin et al. 2017
0.91 (0.81 - 1.03)	2015	Modelled	Gao et al, 2015
1.3 (0.40 - 2)	2014	Survey/reported	Gower et al, 2014
3.2 (0.90 - 5.10)	1992	Survey/reported	Xia et al, 1996

Showing out of

Men who have sex with men (MSM) Living with HIV

Download

Value (%)	Year	Type	Source
2.8 (0 - 10)	2019	Modelled	Jin et al. 2017

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
63.3 (52.20 - 73.20)	2019	Modelled	Granados-Garcia V et al, 2019
43.1 (27.50 - 58.60)	2015	Modelled	Degenhardt L et al, 2017

Showing out of

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
1	2019	Modelled	Jin et al. 2017

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
9,795,000 (6,675,000 - 10,832,000)	2015	Modelled	Blach et al, 2017
25,458,900 (20,406,300 - 31,481,900)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
24,638,000 (19,795,300 - 30,301,000)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
23,719,400 (19,114,200 - 29,136,600)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
22,728,400 (18,396,100 - 27,778,100)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
21,687,300 (17,574,200 - 26,360,500)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
20,616,300 (16,717,100 - 24,972,600)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
19,299,500 (15,679,100 - 23,478,800)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
17,665,300 (14,266,800 - 21,707,600)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
15,959,200 (12,807,200 - 19,724,100)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
14,436,000 (11,455,600 - 17,924,100)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
13,358,000 (10,522,400 - 16,716,600)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
12,574,600 (9,891,550 - 15,726,700)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
11,814,100 (9,290,620 - 14,755,200)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
11,167,300 (8,793,230 - 13,930,000)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
10,729,200 (8,463,170 - 13,358,800)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
10,598,400 (8,379,380 - 13,164,000)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
10,716,800 (8,466,600 - 13,279,400)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
10,921,900 (8,650,660 - 13,538,000)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
11,158,100 (8,849,780 - 13,849,900)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
11,370,200 (9,036,230 - 14,115,700)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
11,502,400 (9,152,760 - 14,321,700)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
11,497,300 (9,161,430 - 14,270,200)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
11,386,000 (9,067,760 - 14,093,700)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
11,246,200 (8,970,140 - 13,923,400)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
11,153,100 (8,894,240 - 13,803,200)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
11,183,800 (8,943,820 - 13,841,900)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
14,474,700 (11,551,800 - 17,974,900)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
18,129,700 (14,475,700 - 22,584,500)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
18,807,300 (15,009,600 - 23,434,100)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
19,020,400 (15,118,500 - 23,699,700)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
19,120,200 (15,235,100 - 23,800,700)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
2,317,000 (1,579,000 - 2,562,000)	2019	Modelled	Dugan et al., 2021

HCV-related death rate

National

Download

Value (Deaths per 100,000)	Year	Type	Source
5.49 (4.53 - 6.48)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
6.76 (5.76 - 7.84)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
6.86 (5.91 - 7.95)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
6.91 (5.95 - 7.88)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
6.99 (6.15 - 7.90)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
6.97 (6.03 - 7.93)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
7 (6.20 - 7.88)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
7.01 (6.16 - 7.91)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
6.79 (6.07 - 7.58)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
6.85 (6.12 - 7.64)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
6.92 (6.16 - 7.73)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
6.62 (5.88 - 7.37)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
5.88 (5.23 - 6.59)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
6.28 (5.57 - 7.05)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
5.55 (4.92 - 6.28)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
5.33 (4.74 - 5.95)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
5.19 (4.63 - 5.81)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
5.06 (4.52 - 5.67)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
4.94 (4.40 - 5.54)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
4.91 (4.35 - 5.54)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
4.8 (4.27 - 5.40)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
4.71 (4.13 - 5.29)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
4.66 (4.08 - 5.29)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
4.69 (4.14 - 5.33)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
4.81 (4.17 - 5.52)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4.35 - 5.75)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
5.12 (4.40 - 5.87)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
5.2 (4.42 - 6.07)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
5.27 (4.48 - 6.11)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
5.49 (4.53 - 6.48)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
5.34 (4.52 - 6.31)	2018	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
10,188	2016	Modelled	WHO
78,041 (64,365 - 92,118)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
78,041 (64,365 - 92,118)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
75,635 (64,114 - 89,393)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
74,406 (63,226 - 86,237)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
72,889 (62,055 - 85,146)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
71,379 (61,337 - 81,831)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
69,367 (60,405 - 79,760)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
66,526 (57,666 - 76,321)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
64,554 (56,885 - 73,386)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
63,780 (55,847 - 72,505)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
64,252 (56,400 - 72,216)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
65,264 (58,032 - 73,446)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
66,402 (58,944 - 74,925)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
66,536 (59,296 - 74,667)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
67,883 (60,591 - 76,095)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
69,278 (61,841 - 77,608)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
70,846 (63,052 - 79,101)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
73,451 (65,161 - 83,123)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
77,443 (68,789 - 86,792)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
82,132 (72,857 - 92,266)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
86,070 (76,439 - 95,900)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
87,732 (78,396 - 97,907)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
87,802 (78,425 - 97,987)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
88,006 (78,322 - 98,344)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
88,240 (78,229 - 99,382)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
87,569 (77,014 - 98,848)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
86,506 (76,209 - 97,842)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
85,383 (73,877 - 97,207)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
83,772 (72,119 - 95,547)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
82,230 (70,887 - 95,298)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
79,999 (68,189 - 92,764)	1990	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
45 (38 - 53)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
46 (40 - 55)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
48 (42 - 56)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
50 (44 - 58)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
52 (46 - 60)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
54 (47 - 61)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
55 (48 - 62)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
56 (49 - 62)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
54 (48 - 60)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
55 (49 - 61)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
50 (44 - 56)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
44 (39 - 50)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
32 (28 - 36)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
27 (24 - 31)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
38 (33 - 42)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
26 (23 - 29)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
26 (23 - 29)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
26 (23 - 29)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
26 (23 - 29)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
25 (22 - 28)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
25 (23 - 28)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
26 (23 - 29)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
24 (21 - 27)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
25 (22 - 27)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
27 (24 - 30)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
29 (25 - 32)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
30 (26 - 34)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
29 (26 - 33)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
30 (27 - 34)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
31 (27 - 35)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
18 (15 - 20)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Number of persons treated for HCV

National

Download

Value	Year	Type	Source
200,000	2018	Survey/reported	WHO, 2021

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
4 (3 - 6)	2015	Survey/reported	National Health and Family Planning Commission of the People's Republic of China, 2015.

Technical notes

Price of HCV cure (Average price in public sector for 3 months of DAAs)

National

Download

Value (US $)	Year	Type	Source
4,393.50	2019	Survey/reported	WHO, 2021

Price of HCV cure (Cheapest price in public sector for 3 months of DAAs)

National

Download

Value (US $)	Year	Type	Source
546	2019	Survey/reported	WHO, 2021

HBV National Action Plan

HBV elimination goal

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

2002

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Most (61-100%)

Source: WHO

% of substance use disorder facilities offering hepatitis treatment

Many (31-60%)

Source: WHO

Overview

HBV elimination goal

HCV elimination goal

Prevalence (national)

Modelled

IHME, GBD 2019 (accessed 2022)

IHME, GBD 2019 (accessed 2020)

Survey/surveillance

Hepatitis related deaths (national)

Modelled

IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available

HBV chart

Modelled

IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available

HCV chart

Prevalence < 5

HBV

0.30 (%)

2014, survey/surveillance

(0.20 - 0.50(%))

WHO WPRO, Woodring J et al, 2017

Prevalence PWID

HCV

63.30 (%)

2019, latest modelled

(52.20 - 73.20(%))

Granados-Garcia V et al, 2019

Birth dose vaccination coverage (national)

Survey/surveillance

No. of syringes/PWID/year

Survey/surveillance

HCV

2015

(3 - 6)

National Health and Family Planning Commission of the People's Republic of China, 2015.

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Latest news

CGHE Community of Practice Newsletter: September 2022

30 Sep 2022

Newsletters

View all

Elimination champion

Dr. Ba Wensheng (2019)

For 15 years, he has improved hepatitis B prevention through education, outreach and vaccination among persons living in remote agricultural and high altitude areas of western China.

Mrs. Linda Jiamin Zhang (2020)

I have realized that there is a way to communicate with policy makers and experts and patients to let people know the truth. It’s been step by step with people like me speaking up. It’s easy to change regulations but it takes time to change people’s minds. After 10 years of changing regulations, workplace discrimination still persists. We must now go further to educate people.